Obalon Therapeutics to Raise $10 Million in Private Placement
August 23, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentation
August 07, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Promotes Kelly Huang, Ph.D. to President
August 02, 2018 07:55 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the promotion of Kelly Huang to the position of President, effective August 2, 2018. “Kelly...
Obalon Schedules Second Quarter 2018 Financial Results Conference Call for August 2, 2018 at 8:30 a.m. Eastern Time
July 24, 2018 10:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 24, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon
June 06, 2018 09:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only...
Obalon Announces Upcoming Conference Presentation
June 05, 2018 09:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentation
May 17, 2018 16:31 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces First Quarter 2018 Financial Results
May 10, 2018 16:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Todd Wood joins Obalon Therapeutics, Inc. as Vice President Global Sales
May 07, 2018 16:06 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Todd Wood has joined as Vice President...
Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time
May 04, 2018 10:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...